Real-world pharmacokinetics of venetoclax in patients with acute myeloid leukemia in Japan
Minoru Kanaya, Yuji Mukai, Goichi Yoshimoto, Mirei Kobayashi, Sayaka Kajikawa, Toma Suzuki, Naoki Miyashita, Shinpei Harada, Takashi Ishio, Emi Yokoyama, Koh Izumiyama, Makoto Saito, Masanobu Morioka, Akio Mori, Toshihiro Matsukawa, Masahiro Onozawa, Mitsuru Moriyama, SungGi Chi, Kosuke Doki, Takano · 2026
Read Real-world pharmacokinetics of venetoclax in patients with acute myeloid leukemia in Japan by Minoru Kanaya, Yuji Mukai, Goichi Yoshimoto, Mirei Kobayashi, Sayaka Kajikawa, Toma Suzuki, Naoki Miyashita, Shinpei Harada, Takashi Ishio, Emi Yokoyama, Koh Izumiyama, Makoto Saito, Masanobu Morioka, Akio Mori, Toshihiro Matsukawa, Masahiro Onozawa, Mitsuru Moriyama, SungGi Chi, Kosuke Doki, Takano (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13234603.txt.
Description
Key Points•Plasma VEN concentration in patients with AML is potentially helpful in predicting prolonged neutropenia.•A low WBC count and impaired renal function heighten the risk of elevated VEN, causing prolonged neutropenia. Introduction Historically, the prognosis of acute myeloid leukemia (AML) in older patients ineligible for intensive chemotherapy has been poor.
Catalog record
| CREATOR | Minoru Kanaya, Yuji Mukai, Goichi Yoshimoto, Mirei Kobayashi, Sayaka Kajikawa, Toma Suzuki, Naoki Miyashita, Shinpei Harada, Takashi Ishio, Emi Yokoyama, Koh Izumiyama, Makoto Saito, Masanobu Morioka, Akio Mori, Toshihiro Matsukawa, Masahiro Onozawa, Mitsuru Moriyama, SungGi Chi, Kosuke Doki, Takano |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |